| Time | Session |
|---|
|
09:20
09:45
|
Drugging transcription factors: HSF1 and Brachyury
|
|
09:45
09:55
|
Proffered Paper: Inhibition of WEE1 kinase activity to overcome secondary resistance to targeted therapies in colorectal cancer
EACR25-0376
EACR25-0376
|
|
09:55
10:20
|
Targeting chromatin proteins for therapeutic benefit in haematological malignancy
|
|
10:20
10:30
|
Proffered Paper: Reversing Acidic Immune Suppression in Cancer with PTT-4256, A First-In-Class Small Molecule Inhibitor of GPR65
EACR25-0553
EACR25-0553
|
|
10:30
10:55
|
PP2A inhibitor protein CIP2A is a prime target for TNBC therapy
|